JohnAVestMD
Cardiology • New York, NYCardiac Electrophysiology
Assistant Professor, Medicine, Columbia University College of Phys & Surg
Are you Dr. Vest?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 91 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
New York Presbyterian Hospital
630 West 168th Street, Ph3-347
New York, NY 10032Phone+1 212-305-8194
Summary
- Dr. John Vest, MD is a cardiologist in New York, New York. He is currently licensed to practice medicine in New York. He is an Assistant Professor at Columbia University College of Phys & Surg.
Education & Training
Brigham and Women's Hospital/West Roxbury Veterans Affairs Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2006 - 2007
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2002 - 2006- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
NY State Medical License 1999 - 2012
Clinical Trials
- HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy Start of enrollment: 2019 Nov 26
Publications & Presentations
PubMed
- 10 citationsImpact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy.Pablo Garcia-Pavia, Martha Grogan, Parag Kale, John L Berk, Mathew S Maurer
European Journal of Heart Failure. 2024-02-01 - 571 citationsFKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac DeathXander H.T. Wehrens, Stephan E. Lehnart, Fannie Huang, John A. Vest, Steven Reiken
Cell. 2003-06-27 - 273 citationsDefective Cardiac Ryanodine Receptor Regulation During Atrial FibrillationJohn A. Vest, Xander H.T. Wehrens, Steven Reiken, Stephan E. Lehnart, Dobromir Dobrev
Circulation. 2005-04-26
Press Mentions
Alnylam Announces New Data from ATTR Amyloidosis Programs at the Peripheral Nerve Society’s 2021 Annual MeetingJune 7th, 2021- FDA Panel Supports Patisiran for ATTR Amyloidosis with CardiomyopathySeptember 15th, 2023
